AMYT Projected Dividend Yield

ADR (Sponsored)/Amryt Pharma PLC ( NASDAQ : AMYT )

Amryt Pharma is a commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing treatments for rare diseases. Co.'s portfolio is comprised of commercial rare disease products, as well as a development-stage pipeline focused on rare skin diseases. Co.'s commercial products include: lomitapide for the treatment of homozygous familial hypercholesterolemia; metreleptin for the treatment of generalized lipodystrophy and partial lipodystrophy; and Mycapssa® (octreotide capsules), which is approved in the U.S. for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.

20 YEAR PERFORMANCE RESULTS